So, CGB have ditched acquiring Medcan and fitting out their own...

So, CGB have ditched acquiring Medcan and fitting out their own facility, which many of you said this facility would put them well ahead of the other asx listed MM companies. Also, I was under the impression this recent cap raise was to fund the fitout of their own facility, which is now not happening lol..?
Do they plan to grow their own medical cannabis at the Biohealth facility aswell, or is it more of just a pharmaceutical manufacturing facility for oils/tablets etc?
I hope for your sakes that this is more concrete than a MOU when it comes time to relist, as far as I’m concerned no big players are going to be investing millions into a company that’s just ditched the plan they’ve been formalizing for the past year while in suspension for most of that year to undertake a MOU with some pharmaceutical company. All imo ofcourse, simply calling it as I see it and not advice in any way.